Loading…
Tuesday, September 29
 

09:00 CEST

Opening Remarks
Tuesday September 29, 2026 09:00 - 09:30 CEST
Inaugural speeches by the President of the Association and authorities
Speakers
avatar for Cristina Nadal Sanmartin

Cristina Nadal Sanmartin

Directora ejecutiva de Policy de MSD en España, MSD
President of AseBio since December 2025.
Since July 2020, she has held the position of Executive Director of Policy & Government Affairs at the pharmaceutical company Merck, Sharp & Dohme de España, S.A.
Since December 2023, she has been Second Vice President of the Spanish Asso... Read More →
Tuesday September 29, 2026 09:00 - 09:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

10:15 CEST

Inside Spanish Biotech VC Playbooks: What Moves the Investment Needle
Tuesday September 29, 2026 10:15 - 11:00 CEST
Want to tilt the odds in your favor on the roadshow? Hear it straight from the source: Spain’s top biotech VCs will unveil their investment playbooks—how they judge scientific risk, vet team credentials and experience, assess development plans, and prioritise therapeutic areas. Each investor gets a brisk, 9-minute spotlight to explain what truly moves the needle. Walk away with a sharper sense...
See More →
Moderators
avatar for Guillermo Serrano

Guillermo Serrano

PartNer, Checkpoint Partners

Speakers
avatar for Arturo Urrios

Arturo Urrios

Partner, Ysios Capital
Arturo leads early-stage investments and company creation at Ysios Capital, driving the firm’s early-stage initiative.Previously, he worked at M Ventures and most recently at Wellington Parties, where he was involved in multiple financings including Riffyn (acquired by Siemens... Read More →
avatar for Tracy Weightman

Tracy Weightman

Montana Children's Health Venture Fund

avatar for Laura Rodríguez Gallego

Laura Rodríguez Gallego

Partner, Invivo Partners

avatar for Clara Campás

Clara Campás

Managing partner and co-founder of Asabys, Asabys Partners
Managing partner and co-founder of Asabys. Clara currently serves on the board of directors of Ona Therapeutics, Nuage Therapeutics, ALLOX and Augustine Therapeutics.Formerly, Clara served as Strategy & Development Director at Kern Pharma and held several positions at Advancell, including... Read More →
avatar for María Poveda

María Poveda

Director Alternative Assets I Life Sciences, Inveready
María joined Inveready in 2018, she is responsible of identifying investment opportunities and leading the investment process. She has actively contributed to the construction of Inveready Biotech III’s portfolio. Furthermore, she provides support and monitors the performance of... Read More →
Tuesday September 29, 2026 10:15 - 11:00 CEST
4 Raúl Martín room

10:15 CEST

Biologics as Strategic Capability: Europe's Production Base in a New Security Era
Tuesday September 29, 2026 10:15 - 11:00 CEST
The ongoing challenges at Europe's borders and beyond, the lingering effects of COVID-19, and the shifting landscape of biological threats have fundamentally reshaped the way Europe must approach its biologic sector. Vaccines, therapeutics, and diagnostics are no longer just healthcare solutions, they are essential strategic assets. Europe's ability to produce these tools quickly, at scale, and on...
See More →
Moderators
avatar for Carlota Gómez de la Hoz

Carlota Gómez de la Hoz

Chief Corporate Affairs & Sustainability Officer, LABORATORIOS HIPRA S.A.
Carlota Gómez de la Hoz has extensive experience in the pharmaceutical industry, where she has held senior management positions related to corporate affairs and sustainability at an international level. In her current role at the biotechnology company HIPRA, she has championed the... Read More →
Tuesday September 29, 2026 10:15 - 11:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

11:00 CEST

Coffee break
Tuesday September 29, 2026 11:00 - 11:30 CEST

Tuesday September 29, 2026 11:00 - 11:30 CEST
4 Raúl Martín room

11:00 CEST

Coffee break
Tuesday September 29, 2026 11:00 - 11:30 CEST

Tuesday September 29, 2026 11:00 - 11:30 CEST
2 Dorotea Barnés room

11:00 CEST

Coffee break
Tuesday September 29, 2026 11:00 - 11:30 CEST

Tuesday September 29, 2026 11:00 - 11:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

11:00 CEST

Coffee break
Tuesday September 29, 2026 11:00 - 11:30 CEST

Tuesday September 29, 2026 11:00 - 11:30 CEST
3 Nicolás Achúcarro room

11:30 CEST

Progress and challenges of advanced therapies for rare diseases
Tuesday September 29, 2026 11:30 - 12:00 CEST
Dr. Bueren leads the Biomedical Innovation Unit at CIEMAT and also conducts research at CIBERER and the Jiménez Díaz Foundation Health Research Institute. Throughout his career, he has made decisive contributions to the development of new gene and cell therapies targeting rare and hereditary diseases, driving the translation of research from the laboratory to clinical practice.Internationally...
See More →
Speakers
avatar for Juan A. Bueren Roncero

Juan A. Bueren Roncero

Director Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)
Head of the Division of Innovative Therapies in the Hematopoietic System at CIEMAT and CIBER of Rare Diseases of the ISCIII, as well as Coordinator of the Joint Unit for Advanced Therapies CIEMAT/IIS-Jiménez Díaz Foundation. Vice President of the ESGCT.
Tuesday September 29, 2026 11:30 - 12:00 CEST
2 Dorotea Barnés room

11:30 CEST

Choosing the Basque Country to grow your business in life sciences and health – discover the reasons
Tuesday September 29, 2026 11:30 - 12:15 CEST
Since the launch of the BioBasque strategy in 2002, Euskadi has invested in consolidating an innovation ecosystem which supports the growth of the health and life sciences industry. Under the overarching strategy of clusters as models for growth of sophisticated sectors, a sustained institutional support and the public-private collaboration have leveraged the development of a growing industry...
See More →
Moderators
avatar for María Aguirre

María Aguirre

Head of Health and Sociohealth transition, SPRI

Speakers
avatar for Lourdes Basabe

Lourdes Basabe

Principal Investigator. Leader of the BIOMICs microfluidics Team, University of the Basque Country
Independent researcher interested in the field of micro bioengineering and lab-on-a-chip technologies. Ikerbasque Research Professor since 2012, Director of the Microfluidics & BIOMICS Cluster UPV/EHU since 2019, Principal Investigator of the BIOMICS-microfluidics Research team since... Read More →
avatar for Iñaki Gutiérrez Ibarluzea

Iñaki Gutiérrez Ibarluzea

Director of Health Research, Innovation and Evaluation, Health Service of the Basque Country

avatar for Javier García Cogorro

Javier García Cogorro

General Partner, Columbus Venture Partners
Founding Partner at Columbus Venture Partners, Javier García spent 25 years at Eli Lilly and Company, where he held various executive positions in Business Development and Information Systems. Since 2009, he has focused on venture capital investment, particularly in private comp... Read More →
avatar for Idoia Muñoz Lizán

Idoia Muñoz Lizán

Managing Director, Basque Health Cluster

Tuesday September 29, 2026 11:30 - 12:15 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

11:30 CEST

What’s the Secret Sauce Behind a Successful Spin-off?
Tuesday September 29, 2026 11:30 - 12:15 CEST
Key success factors behind high-performing spin-offs, including team, science, funding strategy and execution. What to take into account in the early stages to move fast, de-risk projects and build strong foundations for growth. Insights and lessons learned from real cases and different stakeholder perspectives.Agnés Arbat (Oxolife) - Spanish biotech founderGustavo Fuster (Hoffmann Eitle) - IP...
See More →
Moderators
avatar for Anna Bellmunt

Anna Bellmunt

Senior Associate, Asabys Partners
Senior Associate at Asabys, where she joined in 2021, Anna is responsible for sourcing and assessing opportunities from the scientific, development and business perspectives. Anna currently serves as a board observer at Ona Therapeutics and Nuage Therapeutics.Previously, Anna was... Read More →
Tuesday September 29, 2026 11:30 - 12:15 CEST
4 Raúl Martín room

11:30 CEST

Startup pitch presentations: Bioeconomy
Tuesday September 29, 2026 11:30 - 12:15 CEST
Meet innovative startups that are seeking funding to address some of the key challenges of our society. From global warming to the challenge of feeding more than 8 billion people or the need to manage waste and byproducts, biotechnology is offering creative solutions and alternatives.Start-ups will have the opportunity to present their business plans to a panel of investors. Attendees will be...
See More →
Speakers
avatar for Helena García Cebollada

Helena García Cebollada

CEO, BioPredX
Helena García Cebollada (she/her) is the CEO of BioPredX. After getting her PhD in Bioinformatics in 2022, she continued developing predictive software for proteins and genetic variants in her postdoctoral work. This was the starting seed for BioPredX, which she founded in 2026 in... Read More →
avatar for Pablo Montequín

Pablo Montequín

CEO & Co-founder, Calfix
Entrepreneur and legal professional with a Master’s in Intellectual Property & Technology, bringing a proven track record in driving industrial, biotech, and tech projects across Latam, Ireland, and Israel. Heads strategic growth and fundraising initiatives, bridging the gap between... Read More →
avatar for Josune Ayo

Josune Ayo

CEO, Genbioma
Josune Ayo, Ph.D., CEO and co-founder of Genbioma. Ph.D. in Food Technology (UCM) with over 25 years of experience in food innovation. Research background includes 40 publications and four patents, focused on developing foods with nutritional and health benefits. Active member of Food and... Read More →
avatar for Antxon Caballero

Antxon Caballero

CEO, Heuristik
Antxon is a serial entrepreneur with a successful exit. Antxon studied administration and finances with a masters in Big Data, he has international experience in sales and project management, he co founded Heuristik 6 years ago when a nurse made a wrong identification error to his... Read More →
avatar for Mariano Oto

Mariano Oto

CEO, Nucaps
Mariano Oto. Bachelor’s Degree in Economics and Business Sciences, with postgraduate studies in international trade. Entrepreneur and senior executive with more than 20 years of experience in business leadership, commercial strategy, and innovation management. Since 2017, CEO of... Read More →
Tuesday September 29, 2026 11:30 - 12:15 CEST
3 Nicolás Achúcarro room

12:15 CEST

Beyond Discovery: How AI, Advanced Therapeutics and Clinical Evidence Are Reshaping Biotech Innovation
Tuesday September 29, 2026 12:15 - 13:00 CEST
The biotechnology sector is entering a new era in which innovation is no longer driven by scientific discovery alone. The increasing convergence of artificial intelligence, advanced therapeutic approaches, and data-driven clinical decision-making is fundamentally transforming the way new healthcare solutions are conceived, developed, validated, and ultimately delivered to patients. As scientific...
See More →
Speakers
avatar for Juan Sebastián Ruiz

Juan Sebastián Ruiz

CEO, APTADEGRAD
CEO de Aptadegrad y Lincbiotech.  Licenciado y basado en Madrid/Santiago de Compostela, lidera la spin-off biomédica Lincbiotech  del IDIS especializada en el diagnóstico y tratamiento de enfermedades neurológicas graves (como el Alzheimer y el ictus) utilizando intelige... Read More →
avatar for Alejandro Martí

Alejandro Martí

CEO, Votum Labs
Alejandro Martí, junto a Borja Vera, fundó Votum Laboratorios en 2021 con el objetivo de transformar la salud y el bienestar a través de cannabinoides seguros, eficaces y avalados por la ciencia. En apenas tres años, la empresa ha lanzado varias líneas de producto propias para personas y mascotas, certificado su... Read More →
avatar for Manuel Vielma

Manuel Vielma

CEO, E-PISTEME
Manuel Vielma, CEO y fundador de E-Pisteme, startup edTech de la Comunidad LN, trabajan impulsando el aprendizaje STEM a través de experiencias inmersivas, tecnología y creatividad. Gracias a soluciones como E-Tellurion, su kit interactivo sobre el sistema solar, los estudiantes... Read More →
Tuesday September 29, 2026 12:15 - 13:00 CEST
2 Dorotea Barnés room

12:15 CEST

Europe’s Biotech Moment: What the Biotech Act Must Deliver
Tuesday September 29, 2026 12:15 - 13:00 CEST
The year 2025 has been marked by the Biotech Act, the proposed Regulation through which the European Commission aims to establish a comprehensive regulatory framework to foster investment, innovation, and competitiveness in the biotechnology sector at a pivotal moment for Europe's strategic autonomy.Against this backdrop, this session will explore how the Biotech Act represents an opportunity to...
See More →
Speakers
avatar for Javier Padilla Bernáldez

Javier Padilla Bernáldez

Secretary of State, Ministry of Health

avatar for Cristina Nadal Sanmartin

Cristina Nadal Sanmartin

Directora ejecutiva de Policy de MSD en España, MSD
President of AseBio since December 2025.
Since July 2020, she has held the position of Executive Director of Policy & Government Affairs at the pharmaceutical company Merck, Sharp & Dohme de España, S.A.
Since December 2023, she has been Second Vice President of the Spanish Asso... Read More →
Tuesday September 29, 2026 12:15 - 13:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

12:15 CEST

Startup Pitch Presentations: Oncology
Tuesday September 29, 2026 12:15 - 13:15 CEST
Companies seeking funding to develop treatments in neurology and oncology will present their companies and pitch their business opportunity.Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027.Ability Pharmaceuticals, SA  – Carles Domènech, CEOInnoup Farma Kinsy, S.l.  –  Elisa Longás, Chief...
See More →
Speakers
avatar for Carles Domènech

Carles Domènech

CEO, Ability Pharma, S.A.
Carles Domènech, PhD, is Executive Chairman, CEO and co-founder of AbilityPharma, with 30+ years of international experience in biotech, pharma business development, licensing and venture capital. He holds a Biology degree and PhD from Universitat Autònoma de Barcelona, plus business... Read More →
avatar for Elisa Longás

Elisa Longás

Chief Business Officer, Innoup Pharma
Elisa Longás is Chief Business Officer at InnoUp Farma, where she leads corporate strategy, business development and global partnering initiatives. She combines scientific and biotech & pharmaceutical business expertise to drive strategic growth opportunities and international collaborations... Read More →
avatar for Cristina Aguilera

Cristina Aguilera

CEO, Labsinlove
Cristina Aguilera Xiol, PhD MBM, is CEO of Labsinlove and has an international background in biotechnology, translational medicine and innovation management. She started her career in academia as a researcher and later worked internationally across both academia and industry, including... Read More →
avatar for Ana Bouchet

Ana Bouchet

CEO, Lifesome Therapeutics, S.L.
Ana Bouchet is the Co-founder and CEO of Lifesome Therapeutics. She holds a degree in Biotechnology and a PhD in Lipid Biophysics. Her research interests include nanotechnology, molecular delivery, and biophysics applied to biomaterials. In 2022, she spearheaded the company’s growth... Read More →
avatar for Jessika Valero Gonzalez

Jessika Valero Gonzalez

Business Director, Mimo Biosciences
Jessika Valero González, PhD, leads Business Development and Strategy at MIMO Biosciences, where she drives growth, strategic partnerships, and market expansion. With extensive experience in biotechnology innovation and commercialization, she focuses on connecting breakthrough science... Read More →
avatar for Andri Leonidou

Andri Leonidou

Head Of Bi And Corporate Affairs, Nuage Therapeutics
Andri Leonidou is Head of Business Intelligence and Corporate Affairs at Nuage Therapeutics, responsible for competitive intelligence, partnership assessments, and strategic insights to support the company's pipeline and business development activities. She holds a PhD in breast cancer... Read More →
avatar for Teresa Rodríguez-Carmona García

Teresa Rodríguez-Carmona García

Business Development Associate, Oncomatryx Biopharma SA
Teresa is a business development associate at Oncomatryx Biopharma S.A. since October 2025. She supports BD activities by contributing to strategic partnerships, market analysis and stakeholder engagement for preclincial and clinical programs. Teresa holds a Bsc (Honours) in Biomedical... Read More →
avatar for Jesús Martin Garcia

Jesús Martin Garcia

CEO, Peptomyc, S.L.
Jesús Martín García is CEO of Peptomyc, with over two decades of leadership in drug development, biotech strategy and corporate finance. He has held CEO and Board roles, leading clinical-stage programs, partnering transactions and capital raises from Series A through IPO. He holds... Read More →
avatar for Marta Compte Grau

Marta Compte Grau

R&D Director, Trimerbody Pharma
Marta Compte Grau MD, PhD Immunologist and biotech executive with more than 15 years of experience in immuno-oncology, antibody engineering and translational development of biologics. Currently leading scientific, operational and strategic activities at Trimerbody Pharma, advancing... Read More →
Tuesday September 29, 2026 12:15 - 13:15 CEST
4 Raúl Martín room

13:00 CEST

Lunch Break
Tuesday September 29, 2026 13:00 - 14:30 CEST

Tuesday September 29, 2026 13:00 - 14:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

13:00 CEST

Lunch Break
Tuesday September 29, 2026 13:00 - 14:30 CEST

Tuesday September 29, 2026 13:00 - 14:30 CEST
2 Dorotea Barnés room

13:00 CEST

Lunch Break
Tuesday September 29, 2026 13:00 - 14:30 CEST

Tuesday September 29, 2026 13:00 - 14:30 CEST
3 Nicolás Achúcarro room

13:15 CEST

Lunch Break
Tuesday September 29, 2026 13:15 - 14:30 CEST

Tuesday September 29, 2026 13:15 - 14:30 CEST
4 Raúl Martín room

14:30 CEST

Boosting biotechnology development accelerators
Tuesday September 29, 2026 14:30 - 15:15 CEST
The Biotech Act will establish the first comprehensive framework to promote biotechnology as a strategic sector for the European Union’s competitiveness, public health, sustainability, and technological autonomy. The law aims to position Europe in the global competition with the United States and China in this strategically important field.About fostering biotechnology startup companies in the...
See More →
Moderators
avatar for Amelia Martín Uranga

Amelia Martín Uranga

Director of Clinical and Translational Research, FARMAINDUSTRIA
Amelia Martín Uranga, PhD in Law, Director of Clinical and Translational Research and Head of the Innovative Medicines Platform (Farmaindustria), focuses primarily on the implementation and management of public-private partnership projects, such as the BEST Project and the Pharma-Biotech... Read More →
Speakers
avatar for María José Lallena Jimeno

María José Lallena Jimeno

Directora del Centro de Investigación, Desarrollo e Innovación, Fundación LILLY
Doctora en Bioquímica y Biología Molecular por la Universidad Autónoma de Madrid. Su trayectoria profesional se inició con dos periodos postdoctorales: el primero de ellos en el Centro de Biología Molecular de Madrid y el segundo, en el Laboratorio Europeo de Biología Molecular... Read More →
avatar for Idoia Muñoz Lizán

Idoia Muñoz Lizán

Managing Director, Basque Health Cluster

avatar for Núria Martí

Núria Martí

Director of Innovation and Business Development, Biocat
Núria Martí Ras has an undergraduate degree in Veterinary Sciences (Autonomous University of Barcelona, 1993), PhD in Veterinary Sciences (UAB, 1999), master’s in Laboratory Animal Science and Welfare (UAB, 2009) and a master’s in R&D Management in Health from the Carlos III... Read More →
avatar for Javier Jiménez

Javier Jiménez

Chief Medical Officer, Pharmamar
Experienced healthcare professional with over two decades of experience leading evidence generation strategies and research at some of the world’s most prestigious pharmaceutical and health technology companies. As Chief Medical Officer at PharmaMar, I drive the integration clinical... Read More →
avatar for Marisol Quintero

Marisol Quintero

COO, Highlight Therapeutics

Tuesday September 29, 2026 14:30 - 15:15 CEST
2 Dorotea Barnés room

14:30 CEST

From Zero to GMP. Built to Scale
Tuesday September 29, 2026 14:30 - 15:15 CEST
Ponentes:
Dámaso Molero
Reprsentante de Sartorius,
Reopresentante de un cliente
Representante de ingeniería
Speakers
avatar for Dámaso Molero Sánchez

Dámaso Molero Sánchez

Group Chief Executive Officer, 3P Biovian
Experienced General Manager with a demonstrated successful history of more than 34 years working in Pharma and Biotechnology industry. Plant Director, Qualified Person and others. Member of Executive Board of ASEBIO (Spanish Asociation of Bio Companies) Member as an expert of "High-Level... Read More →
Tuesday September 29, 2026 14:30 - 15:15 CEST
3 Nicolás Achúcarro room

14:30 CEST

Joint Opportunities for the UK and Spain through Horizon Europe Collaborations.
Tuesday September 29, 2026 14:30 - 15:15 CEST
As the Guest Nation of BIOSPAIN 2026, the United Kingdom takes centre stage in this high-level round table exploring how UK–Spain collaboration can drive innovation, competitiveness and growth across the life sciences sector through Horizon Europe. Bringing together leading British and Spanish voices from across biotech, research, innovation and public-sector collaboration, this session will...
See More →
Speakers
avatar for Marcel de Matas

Marcel de Matas

Founder & Chief Business Officer, Seda Pharmaceutical Development & Clinical Manufacturing Services
Marcel is Founder and Chief Business Officer at Seda, a company focussed on delivering chemistry manufacturing and controls (CMC) and clinical pharmacology services. The company is located in Cheadle, Stockport and supports companies across UK, Europe, US, Asia and Australia.

Marcel has led the growth of technical capabilities and services at Seda, and has been instrumental in its transformation from a consultancy based business to an internationally recognised contract research, development, and manufacturing organisation. Services include the development

... Read More →
avatar for Ceri Morgan

Ceri Morgan

Trade Commissioner, Europe, Department for Business and Trade
Ceri Morgan is His Majesty’s Trade Commissioner for Europe, with responsibility for encouraging trade and investment between the UK and other European countries, as well as Israel. In her most recent position, she led the Department for Environment, Food and Rural Affairs... Read More →
Tuesday September 29, 2026 14:30 - 15:15 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

14:30 CEST

Spanish biotech spin-offs and their integration into the global ecosystem: reaching out and attracting EU, US and Asia players.
Tuesday September 29, 2026 14:30 - 15:15 CEST
Spanish biotech spin-offs are stepping onto the global stage like nimble launchpads of innovation, pulling in investors and partners from Europe, the US and Asia. Rooted in world-class science yet built for translation, they marry academic brilliance with entrepreneurial grit — and with sharper international branding, smoother regulatory pathways and bolder cross-border alliances, they can turn...
See More →
Speakers
avatar for Emilio Erazo Fischer

Emilio Erazo Fischer

Operating Partne, Asabys Partners
Operating partner at Asabys, Emilio joined the team in December 2024. Emilio supports our biopharma portfolio investments in strategy and business development and currently holds the CBO role at ALLOX.Previously, Emilio led external innovation deals at Boehringer Ingelheim, as Director of Global BD&L Oncology, contributing novel pipeline assets and technology platforms. Emilio has fostered pharma-biotech relationships across Europe, the US and Japan, and served as consultant for... Read More →
Tuesday September 29, 2026 14:30 - 15:15 CEST
4 Raúl Martín room

15:15 CEST

Startup Pitch Presentations: Devices & Diagnostics
Tuesday September 29, 2026 15:15 - 15:45 CEST
Build high-impact investor pitches that translate medical-device and in vitro diagnostics innovation into clear financial potential and patient-outcome narratives investors can’t ignore.Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027. Debios Diagnostics — Joan Grasas, CeoManina Medtech — Mónica, Rodríguez...
See More →
Speakers
avatar for Joan Grasas

Joan Grasas

CEO, Debios Diagnostics
Joan Grasas is a catalyser of innovation and entrepreneurship. His background includes experience at the Institut Català de la Salut, the largest healthcare provider in Catalonia, and long-standing involvement with EIT Health. He has co-founded and led healthtech and IVD projects... Read More →
avatar for Mónica de la Vega

Mónica de la Vega

CEO, Manina Medtech
Monica is the co-founder and CEO of Manina Medtech. She has a Ph.D. in Biochemistry, 20+ years of research in life sciences, and a master's degree in Biodesign, Innovation, and Healthcare Entrepreneurship. Monica previously worked with RehaBeats, an online cardiac rehabilitation startup... Read More →
avatar for Nicolás López de Aguileta Castaño

Nicolás López de Aguileta Castaño

CTO, Oppotunitiy Health
Biomedical Engineer and CTO of Opportunity Health, a medtech company developing connected respiratory care solutions. Nicolás specializes in medical device development, regulatory strategy and healthcare innovation, with previous experience at the Navarra Health Service, BCN3D and... Read More →
avatar for Francesc Paris Huguet

Francesc Paris Huguet

CEO, Optec4Life

Tuesday September 29, 2026 15:15 - 15:45 CEST
4 Raúl Martín room

15:15 CEST

Advanced therapies and next-gen biotech platforms to deliver global health impact
Tuesday September 29, 2026 15:15 - 16:00 CEST
Advanced Therapies and Next-Gen Biotech Platforms to Deliver Global Health ImpactGiven the relative strength of the Basque Country in industrial biotechnology capabilities—particularly in advanced manufacturing, regenerative medicine, and translational research—this proposal envisions a coherent set of 2–3 interconnected BIOSPAIN 2026 sessions exploring advanced therapies and next-generation...
See More →
Speakers
avatar for Javier Alonso Gómez

Javier Alonso Gómez

General Manager, Litek Pharma

avatar for Jimmy Vanhove

Jimmy Vanhove

CEO, Viralgen
Jimmy Vanhove brings extensive experience in strategy, operational management, and digital transformation in the biotech/pharma industry. He has held various leadership positions with increased responsibility in manufacturing and strategy consulting at multinational companies like... Read More →
avatar for Julio Font

Julio Font

CEO, Histocell

avatar for Francisco Borrego

Francisco Borrego

Ikerbasque Research Professor at Biobizkaia Health Research Institute, IIS Biobizkaia
I hold a Bachelor's and a Doctorate in Medicine and Surgery from the University of Córdoba. After completing my doctoral thesis, I worked for 18 years in the United States. The first 13 years were at the National Institutes of Health (NIH), and the following 5 years at the U.S. Food... Read More →
Tuesday September 29, 2026 15:15 - 16:00 CEST
2 Dorotea Barnés room

15:15 CEST

Bizkaia, an entrepreneurial region: building instruments to boost strategic sectors
Tuesday September 29, 2026 15:15 - 16:00 CEST
Bizkaia has developed its own model for promoting strategic sectors, based, on the one hand, on the territory's capacity to design and activate advanced tax instruments, and on the other hand, on the creation of new financing vehicles that combine private contributions or facilitate access to cutting-edge enabling technologies. In this round table, representatives from the Bizkaia Provincial...
See More →
Moderators
avatar for Olatz Goitia Urquiaga

Olatz Goitia Urquiaga

General Director, BEAZ

Speakers
avatar for Antonio Pérez Delgado

Antonio Pérez Delgado

Director General de Hacienda de Bizkaia, Diputación Foral de Bizkaia
Bachelor of Science in Economics and Business Administration from the University of the Basque Country. Professional experience: Electronic Verification Code: Z7KL-QD8W-Z0CE-7XN5. Verification address: www.ebizkaia.eus. In 1985, he worked for six months as an economist for the Provincial... Read More →
Tuesday September 29, 2026 15:15 - 16:00 CEST
3 Nicolás Achúcarro room

16:00 CEST

AI and quantum computing in drug discovery: transforming molecular design and therapeutic development
Tuesday September 29, 2026 16:00 - 16:45 CEST
Quantum technologies are rapidly evolving from theoretical promise to practical tools across biomedicine and biotechnology. Early applications in drug discovery, molecular simulation, quantum enhanced imaging, and secure data infrastructures are already underway, supported by hybrid quantum–classical approaches and pioneering industrial collaborations. This panel will bring together experts from...
See More →
Moderators
avatar for Aitor Bergara

Aitor Bergara

Professor of Quantum Physics at UPV/EHU and Director of the EHU Quantum Center., University of the Basque Country

Speakers
avatar for David Hallett

David Hallett

Chief Scientific Officer, RECURSION

avatar for Ibai Díez Palacio

Ibai Díez Palacio

Assistant Professor of Radiology /Group coordinator CNS diseases & Computational Imaging, IIS Biobizkaia/Harvard Medical School
am an Instructor of Radiology with advanced neuroimaging, biomedical and computational expertise. My work has focused on developing cutting-edge neuroimaging methods and pipelines for multimodal neuroimage research. My research background combines a wide range of imaging techniques... Read More →
Tuesday September 29, 2026 16:00 - 16:45 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

16:00 CEST

Engineering the Materials of Life
Tuesday September 29, 2026 16:00 - 16:45 CEST
Engineered living materials (ELMs) are composed, either entirely or partly, of living cells. ELMs entirely composed of living cells are called biological ELMs and they self-assemble via a bottom-up process – e.g. synthetic morphogenesis for organoids’ production. ELMs only partly composed of living cells are called hybrid living materials (HLMs) and are built with a top-down process with...
See More →
Speakers
avatar for Manuel Salmeron Sanchez

Manuel Salmeron Sanchez

ICREA Research Professor / IBEC Director, IBEC (Institute for Bioengineering of Catalonia)
Manuel Salmerón-Sánchez es Profesor de Investigación ICREA y Director interino del Instituto de Bioingeniería de Cataluña (IBEC), cargo que asumió en enero de 2026. Es bioingeniero experto en biomateriales avanzados para ingeniería celular y medicina regenerativa.
Cargo act... Read More →
Tuesday September 29, 2026 16:00 - 16:45 CEST
3 Nicolás Achúcarro room

16:00 CEST

Making ATMPs Sustainable in 2026: What Gets Funded, Scaled, and Acquired?
Tuesday September 29, 2026 16:00 - 16:45 CEST
Following a market correction, ATMPs are entering a more selective phase where scientific promise must be matched by clear execution. This session will examine what differentiates companies that get funded, scaled, and ultimately acquired. The discussion will focus on investor selection criteria at seed and Series A, including data thresholds, platform differentiation, and capital efficiency. It...
See More →
Moderators
avatar for Robert Fabregat

Robert Fabregat

General Manager, Biocat - Catalan Bioregion
Robert Fabregat (Barcelona, 1980) holds a degree in Chemistry and a PhD in Pharmacy from the University of Barcelona (UB), as well as a Master’s degree in Project Management from BES-La Salle and specific training in Strategy and Innovation from ESADE. From 2019 to 2021, he was... Read More →
Speakers
avatar for Anna Sanramón Giménez

Anna Sanramón Giménez

Manager, VINCES
Anna presta asesoramiento estratégico en asuntos públicos en el ámbito político, legislativo y social a empresas del sector de la salud.Antes de unirse a Vinces, realizó prácticas profesionales en el Ministerio de Asuntos Exteriores, Unión Europea y Cooperación. Posteriormente... Read More →
avatar for Avencia Sánchez Mejías

Avencia Sánchez Mejías

CEO & Co-founder, Integra Therapeutics
Proud to be leading Integra Therapeutics, a biotech company that is creating next-generation gene writing tools to boost the efficiency and safety of advanced therapies to cure genetic and oncological diseases with high unmet medical need.

I have a strong scientific background in

... Read More →
avatar for Jon Alberdi

Jon Alberdi

CEO, VIVEbiotech

avatar for Laura Rodríguez Gallego

Laura Rodríguez Gallego

Partner, Invivo Partners

Tuesday September 29, 2026 16:00 - 16:45 CEST
4 Raúl Martín room

16:00 CEST

Women’s health & care as a growing industry
Tuesday September 29, 2026 16:00 - 16:45 CEST
Women specificities in healthcare are gaining importance due to the higher socieconomical status in developed countries and insights from research highlighting sex and gender disparities in the development, prevention and treatment of diseases. As an example, cardiovascular disease remains the leading cause of death among women in the EU, yet it is still under-researched, frequently misdiagnosed,...
See More →
Moderators
avatar for Iván Macía Oliver

Iván Macía Oliver

Director of Digital Health & Biomecial Technologies, Vicomtech

Speakers
avatar for Idoia Muñoz Lizán

Idoia Muñoz Lizán

Managing Director, Basque Health Cluster

avatar for Carlos Escobar

Carlos Escobar

Cardiologist and co-founder Cofounder SAMIRA DTx, Hostpital La Paz
Education: Bachelor of Medicine and Surgery from the Autonomous University of Madrid (1993-99). Doctor of Medicine from the University of Alcalá, awarded summa cum laude by unanimous decision (2007).

Professional Experience: Attending Physician in Cardiology at the Ramón y Cajal University Hospital in Madrid from 2006 to February 2008. Attending Physician in Cardiology at the Infanta Sofía University Hospital in San Sebastián de los Reyes, Madrid, from February 2008 to May... Read More →
avatar for Marina Rigau

Marina Rigau

CEO & Co-Founder, MiMARK

Tuesday September 29, 2026 16:00 - 16:45 CEST
2 Dorotea Barnés room

16:45 CEST

Advancing Cell & Gene Therapies: Challenges, Innovation & Market Translation
Tuesday September 29, 2026 16:45 - 17:30 CEST
Cell and gene therapies (CGT) have revolutionised the treatment of many conditions and they continue to attract significant levels of investment. Their development faces unique challenges, ranging from technical complexity, regulation, scaling production, and the requirement of innovative commercialization models. This roundtable will explore how CGT can be effectively translated into innovation...
See More →
Speakers
avatar for James Cameron

James Cameron

Market Specialist for Cell & Molecular Research, Agilent NLD
James Cameron is a Market Specialist for BioPharma at Agilent Technologies, specializing in advancing cell and molecular research workflows, mRNA analysis, and critical quality attributes. He frequently acts as a moderator and subject matter expert for key industry discussions. 
... Read More →
avatar for Gaël Roué

Gaël Roué

Junior Group Leader, Josep Carreras Leukaemia Research Institute
Me doctoré en 2002 en la Universidad de Caen (Francia) y trabajé entre 2002 y 2004 como postdoc asociado en el Instituto Pasteur (París, Francia). Posteriormente me trasladé al Hospital Clínic de Barcelona (España) para trabajar en la caracterización de terapias nuevas y traslacionales... Read More →
MA

Miguel Angel Campanero

General Manager, Syngoy

Tuesday September 29, 2026 16:45 - 17:30 CEST
3 Nicolás Achúcarro room

16:45 CEST

Biotech Act: Accelerating Biotech Scale-Up and Building Competitive Value Chains in Europe
Tuesday September 29, 2026 16:45 - 17:30 CEST
Following the publication of the proposed Biotech Act I Regulation, the European Commission has launched a consultation process for the future Biotech Act II, which will focus on industrial policy and on building a broad, forward-looking biotechnology ecosystem.In this session, organised by AseBio, we will examine the opportunities presented by Biotech Act II to advance biomanufacturing and...
See More →
Tuesday September 29, 2026 16:45 - 17:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia
 
Wednesday, September 30
 

09:30 CEST

From Strategy to Collective Action: Building Europe's Agri-Food Biotech Ecosystem Together
Wednesday September 30, 2026 09:30 - 10:15 CEST
Europe has no shortage of ambitious strategies for biotechnology. The challenge now is implementation.Delivering a competitive, resilient and sustainable European agri-food biotechnology ecosystem will require coordinated action across industry, startups, academia, investors, farmers, policymakers and innovation organisations. No single stakeholder can deliver this transformation alone.This...
See More →
Wednesday September 30, 2026 09:30 - 10:15 CEST
3 Nicolás Achúcarro room

09:30 CEST

The Clinical Future of Bioprinting: From biofabrication technologies to next-generation regenerative therapies
Wednesday September 30, 2026 09:30 - 10:15 CEST
Bioprinting is rapidly evolving from an emerging laboratory technology into a transformative clinical platform with the potential to redefine regenerative medicine. This roundtable will bring together key European stakeholders from biofabrication, robotics, clinical translation and advanced manufacturing to discuss how bioprinting can successfully move from research environments into real-world...
See More →
Moderators
avatar for Andrea García Lizarribar

Andrea García Lizarribar

Investigadora de Biomateriales de Salud, TECNALIA
Doctora en Biomedicina por la Universidad de Barcelona. Graduada en Biotecnología por la Universidad de Girona en 2015, donde realizó el trabajo de final de grado en el departamento de bioquímica y biología molecular. Obtuvo el Máster en Biotecnología Molecular de la Universidad... Read More →
Speakers
avatar for Francisco Miguel Sánchez Margallo

Francisco Miguel Sánchez Margallo

Director Científico del CCMIJU, Centro de Cirugía de Mínima Invasión Jesús Usón (CCMIJU)
Con más de 30 años de experiencia, el Dr. Sánchez Margallo es el Director Científico del Centro de Cirugía de Mínima Invasión Jesús Usón (CCMIJU), donde ha liderado importantes avances, como la participación del CCMIJU en el primer trasplante pulmonar robótico realizado... Read More →
JM

Jesús María Izco Zaratiegui

Bioproducts Diversification Manager, VISCOFAN

LM

Luc Milbergue

Presidente, POIETIS Biosistems
Luc Milbergue cuenta con experiencia previa en Strategir, Energies & Castors y Base Innovation. Fue Superintendente de Compañía de Burdeos entre 1983 y 1986. Posee una sólida trayectoria profesional que incluye desarrollo de nuevos negocios, ventas, desarrollo de productos, Microsoft... Read More →
Wednesday September 30, 2026 09:30 - 10:15 CEST
2 Dorotea Barnés room

09:30 CEST

[Subordinate debt and alternative funding instruments]
Wednesday September 30, 2026 09:30 - 10:15 CEST
ICO: fondo españa Crece, préstamos subordinados adecuados al tipo de proyecto
BEI: Innothink
BME,
Santiago de Torres ATRYS
OCA
Moderators
avatar for Oscar Salazar

Oscar Salazar

Managing Director European Funds, EURO FUNDING
Managing Director en la unidad de Fondos Europeos en Euro-Funding, donde lidera un equipo multidisciplinar de más de 30 profesionales internacionales, incluido el equipo de la oficina de Bruselas. Con casi tres décadas de trayectoria profesional, ha desarrollado una sólida carrera... Read More →
Speakers
avatar for Guillermo Jiménez Gallego

Guillermo Jiménez Gallego

Director general, AXIS Participaciones Empresariales SGEIC, S.A.S.M.E.

Wednesday September 30, 2026 09:30 - 10:15 CEST
4 Raúl Martín room

10:15 CEST

Startup pitch presentations: Early stage companies
Wednesday September 30, 2026 10:15 - 10:45 CEST
Meet early stage companiesseeking seed/series A fundingAttendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027.Backpacked-Antibody platform  – Izaskun Morillo, Postdoctoral ResearcherExitium Therapeutics  – Angélica Figueroa Conde-Valvís, CSOKorum Diagnostics  – Carla Ferrero Ruedas,...
See More →
Speakers
avatar for Izaskun Morillo

Izaskun Morillo

Postdoctoral Researcher, Backpacked-Antibody platform (EHU)
Izaskun is a postdoctoral researcher in the Antibody Engineering and Membrane Biophysics in Disease group at Biofisika Institute. Since 2021, my research has focused on improving monoclonal antibodies for cancer therapy by enhancing their cargo capacity. This work led to the development... Read More →
avatar for Angélica Figueroa Conde-Valvís

Angélica Figueroa Conde-Valvís

CSO, Exitium Therapeutics
Dra. Angélica Figueroa is a cancer researcher and innovation leader at INIBIC with more than 20 years of experience in molecular oncology, including work at international institutions such as the Medical Research Council-University College London, the National Institute on Aging... Read More →
avatar for Carla Ferrero Ruedas

Carla Ferrero Ruedas

CEO, Korum Diagnostics
CEO of Korum Diagnostics and PhD in Biotechnology specialized in infectious diseases and antimicrobial resistance (AMR). Background in translational research and early-stage technology transfer, developing rapid diagnostic solutions for clinical use. Focused on transforming scientific... Read More →
avatar for Guillem Loren

Guillem Loren

CEO, Lumina
Driving the development of novel light‑activated oncology therapies. PhD in Organic Chemistry and a Master's in Business Management in Biomedicine. My previous experience includes innovation management at a biotech spin-off and the design and synthesis of anticancer PROTACs.
avatar for Andrea Acebes Huerta

Andrea Acebes Huerta

CEO & Cofounder, Platelet Biotechnologies S.l.
Dr. Andrea Acebes Huerta is CEO and Co-founder of Platelet Biotechnologies and a scientist specialized in regenerative medicine and platelet-based therapies. She holds a PhD in Biochemistry from the University of Oviedo, awarded with International Mention and EMBO Fellowship recognition... Read More →
Wednesday September 30, 2026 10:15 - 10:45 CEST
4 Raúl Martín room

10:15 CEST

Regulating Intelligence: Bringing AI-Powered Medical Devices to the European Market under MDR and the AI Act
Wednesday September 30, 2026 10:15 - 11:00 CEST
Artificial intelligence is transforming medical devices, particularly software-based technologies for early disease detection and personalised healthcare. However, in 2026 AI-powered medical devices in Europe will operate under a dual regulatory framework shaped by Regulation (EU) 2017/745 (MDR) and the Artificial Intelligence Act, creating one of the most complex compliance environments...
See More →
Moderators
avatar for Itiziar Alkorta Idiakez

Itiziar Alkorta Idiakez

Professor, Euskal Herriko Unibertsitatea

Speakers
avatar for María Teresa Gómez Manzano

María Teresa Gómez Manzano

Medical Devices Iberia Manager/Medical Devices Lead Auditor, SGS
My professional career began in 2001, at the age of 23, as Quality and Environmental Manager at the multinational company PIMAN, with offices in Alcalá de Henares, Seville, Barcelona, ​​Poland, Morocco, and China, specializing in the metal sector.

Subsequently, in 2002, I joined the consulting firm Alta Calidad Consultores S.L., in the Quality, Environment, and Prevention Department. For the next four years, I held the position of junior consultant and later senior consultant. My responsibilities included providing legal advice... Read More →
avatar for Javier Zaldua Aguirre

Javier Zaldua Aguirre

CEO & CSO, Accexible Impacto

avatar for Talyta Carteano

Talyta Carteano

New Associate Director, Asphalion
Talyta started at Asphalion as Medical Device Manager and Lead Auditor in 2020, bringing over 10 years’ experience in the Medical Devices field. She combines a technical background with a fulfilling career in the fields of regulatory affairs, quality management systems, devices development and leading people.She has proved to be key to the company since the very beginning thanks to her experience, which covers multiple... Read More →
Wednesday September 30, 2026 10:15 - 11:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

11:00 CEST

Coffee break
Wednesday September 30, 2026 11:00 - 11:30 CEST

Wednesday September 30, 2026 11:00 - 11:30 CEST
2 Dorotea Barnés room

11:00 CEST

Coffee break
Wednesday September 30, 2026 11:00 - 11:30 CEST

Wednesday September 30, 2026 11:00 - 11:30 CEST
3 Nicolás Achúcarro room

11:00 CEST

Coffee break
Wednesday September 30, 2026 11:00 - 11:30 CEST

Wednesday September 30, 2026 11:00 - 11:30 CEST
4 Raúl Martín room

11:00 CEST

Coffee break
Wednesday September 30, 2026 11:00 - 11:30 CEST

Wednesday September 30, 2026 11:00 - 11:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

11:30 CEST

Fishing in the Atlantic Marine Biotech Innovation Ecosystem: from potential to societal impact
Wednesday September 30, 2026 11:30 - 12:15 CEST
Fishing in the Atlantic Marine Biotech Innovation Ecosystem: A Comprehensive Examination of Emerging Scientific and Technological Potential, Pathways for Development and Commercialization, Policy and Governance Challenges, and the Tangible Societal Impacts on Coastal Economies, Public Health, Biodiversity Conservation, and Community Resilience This expanded formulation frames a broad,...
See More →
Moderators
avatar for Elisabete Costa

Elisabete Costa

Scientific and Technology Advisor, Blue Bio Alliance

Speakers
avatar for Tiago H. Silva

Tiago H. Silva

Academic & reserah staff, University of Minho - Biomaterials, Biodegradables and Biomimetics Research Group
PhD in Chemistry (Analytical Chemistry/Electrochemistry) - Universidade do Porto, 2006
 
Graduation in Chemistry (Analytical Chemistry) - Faculdade de Ciências da Universidade do Porto, 2001
 
Research Area:
MARINE INSPIRED BIOMATERIALS: Marine origin polymers and ceramics in Tissue Engineering; Valorization of marine resources and by-products; extraction/isolation and characterization of marine polymers (chitosan, collagen, fucoidan) and ceramics (calcium phosphates and biosilica); development... Read More →
avatar for Marta Conde Sieira

Marta Conde Sieira

Professor, Universidade de Vigo - Marine Research Center
Prof. Marta Conde-Sieira has developed her career in aquaculture, specializing in fish physiology, stress, and appetite regulation. After earning her PhD at the University of Vigo, she conducted postdoctoral research in Portugal, focusing on Senegalese sole and sustainable aquafeeds... Read More →
avatar for Ibon Cancio

Ibon Cancio

Full Professor, University of the Basque Country
Associate Professor in Cell Biology in UPV/EHU, accredited for Full Professorship by Spanish ANECA in May 2010 (positive answer of University for promotion July 2020). He has been coordinator of the official Masters degree in “Environmental Contamination & Toxicology” from 2012... Read More →
Wednesday September 30, 2026 11:30 - 12:15 CEST
3 Nicolás Achúcarro room

11:30 CEST

From Platform to Patient: Scaling Biotech and Advanced Therapies Through Integrated CDMO Ecosystems
Wednesday September 30, 2026 11:30 - 12:15 CEST
As biologics and advanced therapies—including proteins, antibodies, and ATMPs—reshape the therapeutic landscape, the key challenge is no longer only scientific, but industrial. This roundtable will explore how CDMOs are evolving beyond isolated capabilities into integrated, platform-driven ecosystems that accelerate development, reduce risk, and enable efficient path-to-patient.Rather than...
See More →
Moderators
avatar for Andreu Soldevilla

Andreu Soldevilla

CEO, Syna Therapeutics

Speakers
avatar for Laura de la Torre

Laura de la Torre

MK Manager, Leanbio

avatar for Natalia Elizalde

Natalia Elizalde

Chief Business Development Officer, Vivebiotech
Graduate in Pharmacy, she developed her end of degree project at UCLH Hospital in London. Afterwards, she was awarded a European PhD as a result of a thesis (University of Navarra; temporary stay at Oxford University) focused on the long-term effects of chronic mild stress over behaviour... Read More →
avatar for David Blanco Berrenechea

David Blanco Berrenechea

Business Development & Programme Management Director, LeanBio
15 years of experience in biotech and pharmaceuticals business development and project management including PMP certification. Proven business leader with demonstrated success managing global complex CDMO projects in the Pharma and Biotech Industry and integrating all aspects of complex... Read More →
avatar for András Dinnyés

András Dinnyés

Co-founder and General Director, Biotalentum
Co-founder and general director of BioTalentum Ltd. He has been working on embryology, cryobiology, cloning and stem cell biology since 1985. He has been a Fulbright Scholar in the US in 1991-92 and worked at the University of Connecticut (US) for 1997-99, where he invented and patented... Read More →
Wednesday September 30, 2026 11:30 - 12:15 CEST
2 Dorotea Barnés room

11:30 CEST

The Role of Clusters in Fostering the Biotech Ecosystem
Wednesday September 30, 2026 11:30 - 12:15 CEST
1. Conselleiro de Educación, Ciencia, Universidades y FP (Nota: Este seria nuestro Conselleiro, es donde esta integrada la Agencia Gallega de Innovación(GAIN))Román Rodríguez GonzálezMails:[email protected] (Conselleiro de Educación, Ciencia, Universidades y FP)[email protected] (Jefe Gabinete Conselleiro)[email protected] (Secretaria...
See More →
Speakers
avatar for Cristina Nadal Sanmartin

Cristina Nadal Sanmartin

Directora ejecutiva de Policy de MSD en España, MSD
President of AseBio since December 2025.
Since July 2020, she has held the position of Executive Director of Policy & Government Affairs at the pharmaceutical company Merck, Sharp & Dohme de España, S.A.
Since December 2023, she has been Second Vice President of the Spanish Asso... Read More →
Wednesday September 30, 2026 11:30 - 12:15 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

11:30 CEST

Startup Pitch Presentations ATMP
Wednesday September 30, 2026 11:30 - 12:15 CEST
Meet innovative companies developing Advanced Therapy Medicinal Products, which are innovative drugs for human used based on genes, cells or tissue engineering.Start-ups will have the opportunity to present their business plans to a panel of investors. Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN...
See More →
Speakers
avatar for Laia Trigueros Motos

Laia Trigueros Motos

CEO, Amets Biotechnology
Solid track record in biomedical research and strategic leadership, resulting in impactful scientific solutions. Training in business management with the mission of guiding the clinical translation and international growth of Amets Biotechnology.
avatar for Jascha Blobel

Jascha Blobel

Founder & Chief Executive Officer, Golden Gait Biotech
Jascha Blobel is working since over 15 years in the development of biotech companies. Has has been involved in 3 out-licensing deals. As co-founder and CEO of Molomics Biotech, the company was sold to San Fransisco based VeriSIM Life in 2022. Jascha studied chemistry at the Ludwig-Maximilians... Read More →
avatar for Amalia Capilla

Amalia Capilla

CEO, Miramoon Pharma
Dr. Amalia Capilla is CEO of Miramoon Pharma and a biotech executive with 20+ years of experience in regenerative medicine, gene and cell therapy, and translational research. She holds a PhD in Molecular Biology from the University of Valencia and completed postdoctoral training at... Read More →
avatar for Miriam Corredor Sánchez

Miriam Corredor Sánchez

CEO, Nocturna Therapeutics
Miriam Corredor is CEO of NoctuRNA Therapeutics, a biotech company developing novel circular RNA therapeutics for neurodegenerative, neuromuscular and infectious diseases. She holds a PhD in Medicinal Chemistry in neurodegenerative diseases and a Master’s in Business Innovation... Read More →
avatar for Francesca Sarno

Francesca Sarno

CSO, Peaches S.L.
PhD in Biology with 15+ years of experience in translational oncology and advanced therapy development. Formerly involved in CNIO and hospital-based research, with 20+ scientific publications and experience coordinating European R&D projects. As Scientific Director at Peaches Biotech... Read More →
avatar for Iker Ausejo Mauleon

Iker Ausejo Mauleon

COO, Popcorn Therapeutics
Dr. Iker Ausejo Mauleon obtained his Ph.D. in applied medicine and biomedicine from the University of Navarra in 2023, complemented by international experience at the MD Anderson Cancer Center in Houston. Recognized as an emerging talent under 35 in Navarra, he has received 8 prestigious... Read More →
avatar for Ángel Lucio Pereira

Ángel Lucio Pereira

CEO, Tetraneuron S.L.
Angel Lucio is the CEO of Tetraneuron, a Spanish biotech company, advancing gene therapy solutions for Alzheimer’s disease and other neurodegenerative diseases. After several years supporting the company as an advisor and board member, Angel now leads its next phase of growth, as... Read More →
Wednesday September 30, 2026 11:30 - 12:15 CEST
4 Raúl Martín room

12:15 CEST

Can Cooperative Models Transform the Future of Pharma and Healthcare?
Wednesday September 30, 2026 12:15 - 13:00 CEST

Speakers
avatar for Raúl Pérez

Raúl Pérez

Director científico, I+Med.

avatar for Manuel Sánchez-Lagarejo

Manuel Sánchez-Lagarejo

Director general, Bexen Medical & Bexen Bioservices

Wednesday September 30, 2026 12:15 - 13:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

12:15 CEST

From Lab to Market: Financing Spain’s Deep-Tech Future through Innvierte & Tech Transfer
Wednesday September 30, 2026 12:15 - 13:00 CEST
Spain is doubling down on early-stage innovation with the launch of the Innvierte Deep-Tech & Tech Transfer programme, led by CDTI Innovación under the Ministry of Science, Innovation and Universities (MICIU), in collaboration with the European Investment Fund. With a total allocation of €353 million targeting early-stage technologies (TRL 2–4), this initiative aims to close Spain’s...
See More →
Moderators
avatar for Ángel Sánchez

Ángel Sánchez

Partner, Science & Innovation Link Office (SILO)

Speakers
avatar for Moisés Martín Carretero

Moisés Martín Carretero

Director General, CDTI

José Moisés Martín Carretero university degree in economics from the Universidad autónoma de Madrid and has extended graduate programs in finance from the IE Business School, Economic Analysis in the national and international economic relations in the CEPADE from Universidad... Read More →
avatar for Marc Ramis Castellfort

Marc Ramis Castellfort

Founder & Managing Partner, Montana
Marc is passionate about building ventures in the life sciences. He is co-Founder and Managing Partner of the Montana Children’s Health, a venture capital fund managed by Ship2B Ventures, where he focuses on creating and scaling companies dedicated to children’s health and pediatric... Read More →
avatar for Clara Campás

Clara Campás

Managing partner and co-founder of Asabys, Asabys Partners
Managing partner and co-founder of Asabys. Clara currently serves on the board of directors of Ona Therapeutics, Nuage Therapeutics, ALLOX and Augustine Therapeutics.Formerly, Clara served as Strategy & Development Director at Kern Pharma and held several positions at Advancell, including... Read More →
Wednesday September 30, 2026 12:15 - 13:00 CEST
4 Raúl Martín room

12:15 CEST

New Approach Methodologies (NAMs): Accelerating Safer, Smarter and More Human-Relevant Innovation in Drug and Chemical Development
Wednesday September 30, 2026 12:15 - 13:00 CEST
New Approach Methodologies (NAMs) are transforming the way drugs, medical products, and chemicals are evaluated by providing more predictive, human-relevant, and sustainable alternatives to traditional testing approaches. By integrating advanced in vitro models, computational tools, artificial intelligence, in silico toxicology, and innovative preclinical strategies, NAMs offer new opportunities...
See More →
Speakers
NS

Natalia Sánchez

Senior Scientific Advisor, BeCytes Biotechnologies (BioIVT)

avatar for Carmen Martín González

Carmen Martín González

CEO, Founder & Sr Principal Consultant, Cmg Meddev SL

avatar for John Kendrick

John Kendrick

Executive Director, NAMs and Emerging Technologies, Labcorp
Over the past 20 years, I have worked diligently to build and refine my skills in Drug Development, with a particular focus on the scientific elements that make up DMPK. I have continued learning and evolving the skills for scientific and organizational leadership of this discipline... Read More →
avatar for Simón Perera del Rosario

Simón Perera del Rosario

Business Development Manager, ProtoQSAR
Simón. Simón Perera holds a degree in Biotechnology from the Autonomous University of Barcelona and a Master's degree in Biological Anthropology from the University of Barcelona.

He has worked as a project manager and business developer at various companies, including Anaxomics... Read More →
Wednesday September 30, 2026 12:15 - 13:00 CEST
3 Nicolás Achúcarro room

13:00 CEST

Lunch Break
Wednesday September 30, 2026 13:00 - 14:30 CEST

Wednesday September 30, 2026 13:00 - 14:30 CEST
2 Dorotea Barnés room

13:00 CEST

Lunch Break
Wednesday September 30, 2026 13:00 - 14:30 CEST

Wednesday September 30, 2026 13:00 - 14:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

13:00 CEST

Lunch Break
Wednesday September 30, 2026 13:00 - 14:30 CEST

Wednesday September 30, 2026 13:00 - 14:30 CEST
3 Nicolás Achúcarro room

13:00 CEST

Lunch Break
Wednesday September 30, 2026 13:00 - 14:30 CEST

Wednesday September 30, 2026 13:00 - 14:30 CEST
4 Raúl Martín room

14:30 CEST

Accelerating Oncology Innovation: Collaborative Models for Early Translation
Wednesday September 30, 2026 14:30 - 15:15 CEST
The successful translation of early-stage oncology research into therapies that reach patients requires more than scientific excellence. It demands effective collaboration among researchers, technology transfer professionals, biotech companies, patient organizations, investors, and funding institutions. As Europe increasingly embraces collaborative and impact-driven innovation models, new...
See More →
Moderators
avatar for Sofía Cabezudo

Sofía Cabezudo

Head of Innovation, Fundación Científica de la Asociación Española Contra el Cáncer

Speakers
avatar for Laureano Simón

Laureano Simón

CEO, Oncomatryx
Dr. Simón is the founder of Progenika Biopharma S.A. and co-founder of Progenika Inc., Proteomika S.L., and Abytnek Biopharma S.L. Dr. Simón has extensive experience in the diagnostics industry and has collaborated successfully with pharmaceutical companies.
Currently, Dr. Simón is the CEO of Progenika Group, co-CEO of Progenika Inc., and serves as a Director in biotechnology companies in Europe and the United States.He also advises various governments, scientific committees, public institutions, and private foundations on technology... Read More →
avatar for Arkaitz Carracedo

Arkaitz Carracedo

ERC Consolidator Grant Ikerbasque Research Professor Cancer Cell Signaling And Metabolism Lab, CIC Biogune
Arkaitz Carracedo obtained his BSc in Biology from the Complutense University of Madrid, and he continued his scientific pursuits by completing his PhD in Biochemistry and Molecular Biology at the same university. At this early stage in his career, he focused on researching the "... Read More →
avatar for Eider Sánchez

Eider Sánchez

Cofounder & CEO, Naru Intelligence Solutions S.L.

avatar for Fernando Aguirre

Fernando Aguirre

CEO, Hawk Biosystems
MSc in Physics, Fernando has more than 25 years of new business launch leadership across business development, internationalization and M&A, both as an entrepreneur (he has founded 5 companies so far) as well as in global management position in multinational companies such as Ericsson... Read More →
Wednesday September 30, 2026 14:30 - 15:15 CEST
2 Dorotea Barnés room

14:30 CEST

Advancing Transplant Innovation: Bridging Clinical Excellence with Smarter Drug Development
Wednesday September 30, 2026 14:30 - 15:15 CEST
A silent storm is sweeping the globe: chronic kidney failure touches more than 850 million lives, ranks ninth among causes of death, and affects roughly 10% of the world’s population. In Spain alone, 15% of adults live with chronic kidney disease and about 68,000 people require dialysis or transplant to survive. Spain stands out as a beacon of transplant medicine — performing more than 6,000...
See More →
Speakers
avatar for Isabel Portero

Isabel Portero

CSO & Founder, Biohope
Isabel Portero (Salamanca, 1970) is the founder and CEO of Biohope, a startup dedicated to the creation and development of biomedical tests that allow for personalized medical treatment in diseases with an immunological basis. A Doctor of Medicine and specialist in Internal Medicine... Read More →
avatar for Alberto Breda

Alberto Breda

Head of Urologic Oncology and the Renal Transplant Surgical Team, Fundació Puigvert
Deputy Director of the Urology Department | Puigvert FoundationThis position is combined with the direction of the Urologic Oncology Unit and the Renal Transplant Surgical Team. Puigvert Foundation, Barcelona.
President of the Robotic Surgery Section | European Robotic Urology Sec... Read More →
avatar for Beatriz Dominguez-Gil

Beatriz Dominguez-Gil

General Director, National Transplant Organization (ONT)
Beatriz Domínguez-Gil holds a degree in Medicine and Surgery from the University of Salamanca. She earned her doctorate in Internal Medicine from the Complutense University of Madrid and worked as a nephrologist at the 12 de Octubre Hospital in Madrid from 2000 to 2007.Before being appointed director of... Read More →
avatar for Sofía Zárraga Larrondo

Sofía Zárraga Larrondo

Jefa de Servicio de Nefrología en Hospital Universitario de Cruces (Osakidetza)

TS

Tim Schroeder

CEO, CTI Clinical Trial & Consulting
Tim is Executive Chairman and Founder of CTI, bringing more than 35 years of clinical, academic, and industry experience in global drug and device development. Prior to founding CTI, he held numerous faculty positions at the University of Cincinnati College of Medicine. Tim was also... Read More →
Wednesday September 30, 2026 14:30 - 15:15 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

14:30 CEST

Unlocking Opportunities in precision fermentation for the food industry
Wednesday September 30, 2026 14:30 - 15:15 CEST
Imagine a kitchen where tiny, tireless chefs—yeast, bacteria, or fungi—are taught new recipes at the molecular level. That is precision fermentation: a carefully controlled, biology-driven process that programs microorganisms to churn out specific food ingredients, from enzymes and flavor molecules to structurally complex proteins. Using modern genetic and metabolic engineering, these...
See More →
Speakers
avatar for Guadalupe Monserrat Alvarado Jasso

Guadalupe Monserrat Alvarado Jasso

Researcher in culinary biotechnology, Basque Culinary Center/GOe Tech Center
I am a highly accomplished and strategic-minded professional with a Ph.D and a scientific approach to in managing research, development, and innovation projects, with extensive experience in leading multidisciplinary teams and optimizing resources. My scientific and strategic approach... Read More →
avatar for Ana Torrejón Cabello

Ana Torrejón Cabello

Responsable de Microbiología y Biotecnología Industrial, AINIA
Chemical Engineer (Polytechnic University of Valencia, 2006) and Master in Agri-food Biotechnology (University of Valencia, 2019).She is currently the Head of Microbiology and Industrial Biotechnology at AINIA. She has over ten years of experience in scaling up biotechnological processes... Read More →
Wednesday September 30, 2026 14:30 - 15:15 CEST
3 Nicolás Achúcarro room

15:15 CEST

Circularity at Scale: The 2030 Value Chain Challenge
Wednesday September 30, 2026 15:15 - 16:00 CEST
The European Union has positioned the bioeconomy as a cornerstone of its competitiveness, sustainability, and strategic autonomy agenda. The recently launched Strategy for a Competitive and Sustainable EU Bioeconomy seeks to accelerate the transition from innovation to industrial deployment by removing regulatory barriers, scaling investment, creating lead markets for bio-based solutions, and...
See More →
Wednesday September 30, 2026 15:15 - 16:00 CEST
3 Nicolás Achúcarro room

15:15 CEST

Current innovation trends in therapeutic technologies and modalities: what is the potential of Spain to ride these waves?
Wednesday September 30, 2026 15:15 - 16:00 CEST
A guided tour of Spain’s biomedical frontier: where tomorrow’s therapies are being born, who’s driving them, which technologies enable them, and how to convert those breakthroughs into investment and company-building opportunities
Moderators
avatar for Montserrat Vendrell

Montserrat Vendrell

Partner, Asabys Partners
Montse currently serves on the board of directors of Ona Therapeutics, InBrain Neuroelectronics, Peptomyc and Accure. She is also independent director at the board of Oryzon genomics.Formerly, Montse was partner at Aliath Bioventures and Alta Life Sciences. Prior to that, she was... Read More →
Speakers
avatar for Robert Fabregat

Robert Fabregat

General Manager, Biocat - Catalan Bioregion
Robert Fabregat (Barcelona, 1980) holds a degree in Chemistry and a PhD in Pharmacy from the University of Barcelona (UB), as well as a Master’s degree in Project Management from BES-La Salle and specific training in Strategy and Innovation from ESADE. From 2019 to 2021, he was... Read More →
avatar for Gurutz Linazasoro

Gurutz Linazasoro

Neurólogo / Fundador, VIVEbiotech
Gurutz es neurólogo especializado en enfermedad de Parkinson y trastornos neurodegenerativos. Es Director del Programa de Terapias Avanzadas para el Alzheimer y Parkinson del Grupo Quirón Salud-Policlínica Gipuzkoa, y Director del Curso Nacional Anual sobre Trastornos del Movimiento.Gurutz... Read More →
avatar for Gloria González

Gloria González

CIMA, investigadora-Directora de Innovación / CSO en VIVET, Venture partner de Asabys, CIMA
Directora de programa Terapia Génica de Enfermedades Raras.
Investigadora principal del grupo Terapias Avanzadas para Enfermedades Hepáticas Raras.
Dedicación preferencial a la terapia génica enfermedades hepáticas, modelos animales de enfermedades hepáticas.
avatar for Moisés Martín Carretero

Moisés Martín Carretero

Director General, CDTI

José Moisés Martín Carretero university degree in economics from the Universidad autónoma de Madrid and has extended graduate programs in finance from the IE Business School, Economic Analysis in the national and international economic relations in the CEPADE from Universidad... Read More →
Wednesday September 30, 2026 15:15 - 16:00 CEST
2 Dorotea Barnés room

15:15 CEST

Substance Matters: From Microbiome Breakthroughs to EU Benchmarks
Wednesday September 30, 2026 15:15 - 16:00 CEST
Human-derived substances are at the forefront of a new wave of biomedical innovation, spanning cell therapies, microbiome-based interventions, and advanced medicinal products. As these technologies rapidly evolve, so too does the complexity of the regulatory landscape governing their development and clinical application within the European Union. This session will explore the scientific, clinical,...
See More →
Speakers
avatar for Joaquín Antonio Delgadillo Duarte

Joaquín Antonio Delgadillo Duarte

Director Científico, BANCO DE SANGRE Y TEJIDOS
Licenciado en Medicina y Cirugía por la Universidad de Barcelona, con la especialidad de Farmacología Clínica en el Hospital Universitario del Vall d'Hebron, y Doctor en Medicina y Cirugía por la Universidad Autónoma de Barcelona. Ha cursado el Postgrado en Metodologías Estadísticas... Read More →
avatar for Patricia del Río

Patricia del Río

Executive Director, Mikrobiomik
Con más de tres años de trayectoria en Mikrobiomik, Patricia ha sido una pieza clave en su crecimiento, comenzando como Responsable de Ensayos Clínicos y más recientemente como Directora de Desarrollo de Negocios e Innovación.
Antes de unirse a Mikrobiomik, Patricia lider... Read More →
Wednesday September 30, 2026 15:15 - 16:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

15:15 CEST

Startup Pitch Presentations. Drug Development & Delivery
Wednesday September 30, 2026 15:15 - 16:30 CEST
Each company will be given a six-minute spotlight to unveil investment opportunities in drug development and delivery—six minutes to ignite interest and sketch the future of medicine.Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027.Vaxdyn – Juan José Infante Viñolo, CEOFatrixGel  – Pablo...
See More →
Speakers
avatar for Juan José Infante Viñolo

Juan José Infante Viñolo

CEO, Vaxdyn
Dr. Infante leads Vaxdyn and its international collaboration network, advancing vaccines against antibiotic-resistant bacteria. As co-inventor of the company's core technology, he has secured funding from CARB-X, the European Commission and specialist investors. His background combines... Read More →
avatar for Pablo Sanchez-rey

Pablo Sanchez-rey

CEO & Founder, FatrixGel
Biologist and biotechnologist with a PhD in Biological Sciences and over 10 years of experience in the startup ecosystem. Former COO of a Fermentation Biotech, leading operations, strategic execution, and stakeholder relations. Currently CEO and founder of Fatrix Biotech, a biomaterial... Read More →
avatar for Ariadna Boloix Amenós

Ariadna Boloix Amenós

CEO & Co-founder, Flavii Therapeutics
Dr. Ariadna Boloix Amenós is CEO & Co-founder of Flavii Therapeutics S.L., leading corporate strategy and business development. She holds a PhD in Biochemistry and Biomedicine (UAB) and a Pharmacy degree (UB). Her research at the Vall d’Hebron Research Institute and Institute of Materials Science of Barcel... Read More →
avatar for Meritxell Teixidó Turà

Meritxell Teixidó Turà

Ceo & Cso, Gate2brain
Meritxell Teixidó holds a PhD in Organic Chemistry from the University of Barcelona and an eMBA from UOC. She spent more than 15 years at IRB Barcelona leading research on peptides capable of crossing biological barriers, co-supervising 10 PhDs, publishing over 50 scientific articles... Read More →
avatar for Andrea Zapater Matute

Andrea Zapater Matute

R&D Business Developer, i+Med S.coop
Andrea Zapater, PhD, is an R&D Business Development Manager at i+Med, focused on advanced biomaterials and drug delivery technologies for innovative therapeutic applications. She holds a PhD in Personalized Medicine and has experience in biotechnology, translational research, and... Read More →
avatar for Tania Ortuño

Tania Ortuño

Head of Operations, Molefy Pharma SL
Tania Ortuño is a biologist and doctor in Neuroscience with extensive experience combining scientific R&D with business development skills in innovation-driven environments. Her career spans neuroscience research and biotech operations, giving her a multidisciplinary profile at the... Read More →
avatar for Nicolás Galmarini

Nicolás Galmarini

CEO & Co-founder, Nanogrow Biotech
Economist and MBA with over 20 years in the pharmaceutical industry and a proven track record in establishing businesses across Latin America. Holds a BA in Economics from UdelaR and an MBA from Universidad Austral (Argentina). His extensive experience and entrepreneurial mindset... Read More →
avatar for Marie-eve Beaulieu

Marie-eve Beaulieu

General Manager, Nostrum Biodiscovery
Marie-Eve Beaulieu, PhD is General Manager of Nostrum Biodiscovery, a Barcelona- and Boston-based computational drug discovery technology company developing physics-based AI platforms for therapeutic design. She brings over 15 years of experience spanning drug discovery and executive leadership in biotech. Pr... Read More →
avatar for Angel Cebolla Ramírez

Angel Cebolla Ramírez

CEO, Olavide Neuron STX S.L. (ONESTX)
Dr. Ángel Cebolla is a scientist and serial bioentrepreneur with more than 25 years of experience translating academic research into profitable biotech solutions. After founding Biomedal and leading its world-class rapid food diagnostics division to a successful exit with the US... Read More →
avatar for Adolfo Gastalver

Adolfo Gastalver

Co-Founder & CEO, Ploid AI Biotech
Co-Founder & CEO of Ploid AI. Computer and electrical engineer specialized in AI, with two Master's degrees and a PhD candidacy in electrical engineering. Former AI researcher at CSIC-IIIA, with startup and consulting experience at Ingelectus and BCG.
avatar for Ignacio Massone

Ignacio Massone

CEO & Co-founder, Resistia
Former Big Pharma leader with a proven track record in business development and product launches. Currently Co-founder and CEO of Resistia, a deep-tech startup developing microbiome-derived therapies that restore the efficacy of existing antibiotics against resistant infections.

... Read More →
Wednesday September 30, 2026 15:15 - 16:30 CEST
4 Raúl Martín room

16:00 CEST

Advances in Neurodegenerative Diseases: From Novel Therapies to Real-World Clinical Validation
Wednesday September 30, 2026 16:00 - 16:45 CEST
Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Alzheimer's Disease continue to pose major scientific, clinical, and societal challenges. At the same time, unprecedented advances in molecular biology, drug discovery, biomarkers, precision medicine, and advanced therapeutic approaches are transforming the landscape of neurological research and...
See More →
Speakers
avatar for Antonio Oliviero

Antonio Oliviero

CMO, Golden Gait Biotech

Dr. Antonio Oliviero career started in Rome (Catholic University) where he obtained the degree in Medicine (Oct 1993) and the degree in Neurology (Oct 1997). In the same University, Dr Oliviero obtained the PhD in Neuroscience (Jan 8th, 2002). The main research fields of Dr... Read More →
avatar for Adolfo López de Munain

Adolfo López de Munain

Miramoon Pharma & SEED-ALS coordinator/leader, Osakidetza, IIS Biogipuzkoa, Miramoon Pharma
Dr. López de Munain is Chief Scientific Officer and Co-Founder of MiramoonPharma, with over 35 years of experience in clinical neurology, neurogenetics,and translational neuroscience. He holds an MD and a PhD in Medicine from theUniversity of Navarra, where he conducted his doctoral... Read More →
avatar for Ana Martínez Gil

Ana Martínez Gil

Cofounder, Molefy Pharma
Experta en descubrimiento de fármacos y química medicinal, con más de 25 años de experiencia en enfermedades neurodegenerativas. Es profesora de investigación en el CIB-CSIC y cofundadora de Molefy Pharma.
Wednesday September 30, 2026 16:00 - 16:45 CEST
2 Dorotea Barnés room

16:00 CEST

One Health Diagnostics: Rapid Detection and Characterization of Multidrug Resistant Bacteria to Enable Next Generation Antimicrobials
Wednesday September 30, 2026 16:00 - 16:45 CEST
Imagine a crossroads where human health, animal welfare, and the environment meet — and a new generation of sentinels stands guard. This panel will convene those sentinels to tackle the urgent challenge of protecting vulnerable people and animals from disease driven by major antibiotic‑resistant threats, and to showcase the bleeding‑edge tools that spot and dissect multidrug‑resistant...
See More →
Moderators
avatar for Raquel Carnero

Raquel Carnero

Senior Medical Devices Specialist, IQVIA

Speakers
avatar for Juan José Infante Viñolo

Juan José Infante Viñolo

CEO, Vaxdyn
Dr. Infante leads Vaxdyn and its international collaboration network, advancing vaccines against antibiotic-resistant bacteria. As co-inventor of the company's core technology, he has secured funding from CARB-X, the European Commission and specialist investors. His background combines... Read More →
avatar for Larraitz Añorga Gómez

Larraitz Añorga Gómez

Director of Research and Development, Biolan Health SL
R&D Director with a strong scientific background and more than 15 years of experience leading R&D&i projects focused on the design, development, and manufacturing of (bio)sensors (lateral flow immunoassays, electrochemical biosensors based on printing technologies, etc.) for food... Read More →
avatar for Santos Merino

Santos Merino

Senior Researcher & Surface Chemistry and Nanotechnology Unit, TEKNIKER

PhD in Solid State Physics in 1997. Since 2001, he was Head of the Micro and Nanofabrication Unit in IK4-Tekniker and since 2017 he is Head of the Sensors Research Area in the Surface Chemistry and Nanotechnologies Unit. He has worked on different fields such as in-vitro diagnostic tra... Read More →
avatar for Bruno González-Zorn

Bruno González-Zorn

Head of Antimicrobial Resistance Unit and Prof at UCM, Universidad Compluetense de Madrid
Bruno González Zorn, is a prominent microbiologist, scientist, and professor. He is recognized for his pioneering contributions to One Health and antimicrobial resistance (AMR). His work has had a significant impact on the global understanding of zoonotic diseases and the development... Read More →
Wednesday September 30, 2026 16:00 - 16:45 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

16:45 CEST

From Biotechnology to Clinical Intelligence: How to Build Biotech Solutions Powered by Software and AI, Interoperable by Design in Europe. Practical case: use in histopathology for biomarker identification
Wednesday September 30, 2026 16:45 - 17:30 CEST
The integration of biotechnology, software, and artificial intelligence is redefining the development of advanced solutions for diagnosis, patient stratifica on, and precision medicine. However, the effective transla on of these innovations into the European clinical environment requires going beyond analytical performance or the experimental validation of biomarkers. It also requires the ability...
See More →
Moderators
avatar for Carmen Martín González

Carmen Martín González

CEO, Founder & Sr Principal Consultant, Cmg Meddev SL

Speakers
avatar for Valery Naranjo

Valery Naranjo

CTO, ARTIKODE
Experience as professor, researcher and director of CVBLab. Cordination of European projects. Innovation awards, Technology Transfer to Industry.
Catedrática de Teoría de la Señal. Universidad Politécnica de Valencia. Directora de CVBLab. Área de investigación: inteligencia artificial, análisis de imagen, visión por computador, análisis de señal... Read More →
avatar for Anna Rosés

Anna Rosés

Head of Innovation, Hospital Clínic de Barcelona
I lead innovation with a clear focus: turning complex ideas into execution and real-world impact.

My career spans private sector, entrepreneurship and healthcare, across multinational companies, startups and innovation-driven environments. This path has shaped how I work: combining strategic thinking with a strong execution mindset, moving comfortably in ambiguity, aligning diverse... Read More →
MM

Marta Montilla

Senior Global Quality & Regulatory Affairs Leader, CMG MedDev
Quality and Regulatory Leader with 12+ years of international experience in healthcare and in-vitro diagnostics (IVD), integrating R&D, quality, and regulatory frameworks. Skilled in translating complex regulations into internal policies, implementing operational digital systems... Read More →
Wednesday September 30, 2026 16:45 - 17:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia
 
Thursday, October 1
 

09:30 CEST

From Lab Coats to Suits: Essential Roles in the Biotech Journey
Thursday October 1, 2026 09:30 - 10:15 CEST
· Moderación: Persona de LIM Global
· Ponentes:
o Perfil I+D: David Álvarez Ordás (Roche)
o Perfil Manufacturing / Operations: Persona de 3P BIOVAN
o Perfil Regulatory Affairs: Persona de Viralgen
o Perfil Marketing: Persona de HIPRA

Thursday October 1, 2026 09:30 - 10:15 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

10:15 CEST

Magnetize & Maintain: Speeding up attraction, securing long-term retention
Thursday October 1, 2026 10:15 - 11:00 CEST
Mesa redonda 2: “Magnetize & Maintain: Speeding up attraction, securing long-term retention”
· Moderación: Persona de FEBiotec
· Ponentes:
o Perfil consultoría HR: Persona de LIM Global
o Perfil STEM: Persona de Bizkaia Talent
o Perfil formación: Persona de CESIF
o Perfil HR en empresa biotec: Paola Salanueva (Histocell)

Thursday October 1, 2026 10:15 - 11:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

11:00 CEST

Coffee break
Thursday October 1, 2026 11:00 - 11:30 CEST

Thursday October 1, 2026 11:00 - 11:30 CEST
2 Dorotea Barnés room

11:00 CEST

Coffee break
Thursday October 1, 2026 11:00 - 11:30 CEST

Thursday October 1, 2026 11:00 - 11:30 CEST
3 Nicolás Achúcarro room

11:00 CEST

Coffee break
Thursday October 1, 2026 11:00 - 11:30 CEST

Thursday October 1, 2026 11:00 - 11:30 CEST
4 Raúl Martín room

11:00 CEST

Coffee break
Thursday October 1, 2026 11:00 - 11:30 CEST

Thursday October 1, 2026 11:00 - 11:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

11:30 CEST

Unlocking the Lab: Navigating Patents and the Spin-off Landscape
Thursday October 1, 2026 11:30 - 12:15 CEST
· Moderación: Persona de FEBiotec
· Ponentes:
o Perfil patentes: Persona de Manuel Illescas
o Perfil inversor: Persona de Ysios Capital


Speakers
avatar for Malgorzata Rogalska

Malgorzata Rogalska

Analyst, Ysios Capital

avatar for Teresa Riesgo Alcaide

Teresa Riesgo Alcaide

Secretary General for Innovation, Minstry of Science, Innovation and Universities
Professor of Electronic Technology at the Higher Technical School of Industrial Engineers of the UPM (ETSII-UPM), where she has developed her entire teaching and research career.Professional experienceShe has been director of the Center for Industrial Electronics, deputy director of Research and International Relations of the ETSII-UPM and, more recently, director of the Department of Automation, Electrical Engineering and Electronics and Industrial Informatics.Since 2003 she has... Read More →
avatar for Jascha Blobel

Jascha Blobel

Founder & Chief Executive Officer, Golden Gait Biotech
Jascha Blobel is working since over 15 years in the development of biotech companies. Has has been involved in 3 out-licensing deals. As co-founder and CEO of Molomics Biotech, the company was sold to San Fransisco based VeriSIM Life in 2022. Jascha studied chemistry at the Ludwig-Maximilians... Read More →
Thursday October 1, 2026 11:30 - 12:15 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

12:15 CEST

Decoding the Future: AI and the Digital Transformation of Biotech
Thursday October 1, 2026 12:15 - 13:00 CEST
Moderación: Persona de una spin-off no elegida como ponenteo Perfil spin-off: BioComputing o HAWK Biosystems / Ubikare
o Perfil automatización: Persona de Agilent technologies
o Perfil uso IA para búsqueda fármacos: Persona de MSD
o Perfil uso IA en CDMO: Persona de Klinea

Thursday October 1, 2026 12:15 - 13:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

12:30 CEST

Passing the baton to Barcelona
Thursday October 1, 2026 12:30 - 13:00 CEST
With warm thanks to our regional hosts — the Provincial Government of Bizkaia and the Government of the Basque Country — we’re delighted to hand the baton to our friends from Catalonia, who will host the next edition of BIOSPAIN. See you in Barcelona for BIOSPAIN 2027!
Speakers
avatar for Teresa Riesgo Alcaide

Teresa Riesgo Alcaide

Secretary General for Innovation, Minstry of Science, Innovation and Universities
Professor of Electronic Technology at the Higher Technical School of Industrial Engineers of the UPM (ETSII-UPM), where she has developed her entire teaching and research career.Professional experienceShe has been director of the Center for Industrial Electronics, deputy director of Research and International Relations of the ETSII-UPM and, more recently, director of the Department of Automation, Electrical Engineering and Electronics and Industrial Informatics.Since 2003 she has... Read More →
Thursday October 1, 2026 12:30 - 13:00 CEST
Biocat Booth #45
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.